Blum Susan 4
4 · CorMedix Inc. · Filed Jan 27, 2026
Research Summary
AI-generated summary of this filing
CorMedix (CRMD) CFO Susan Blum Receives RSU Award
What Happened
- Susan Blum, Chief Financial Officer of CorMedix Inc. (CRMD), received a grant of 72,820 restricted stock units (RSUs) on 2026-01-23 (acquisition price $0.00).
- To satisfy tax withholding on the award, 9,767 shares were disposed/withheld at $7.27 per share, totaling $71,006. The withholding is recorded under code F (tax withholding).
Key Details
- Transaction date: 2026-01-23; Form 4 filed: 2026-01-27 (filed within the required 2 business days).
- Grant: 72,820 RSUs (acquired at $0.00).
- Withheld for taxes: 9,767 shares disposed at $7.27 each = $71,006.
- Shares owned after the transaction: not specified in the filing.
- Footnote: RSUs (granted 01/23/2026) represent the right to one share each; vesting is 1/4 at grant and then 1/4 on each of the next three anniversaries, subject to continued employment.
- Filing includes Exhibit 24.1 (Power of Attorney).
Context
- RSU grants are a form of compensation (not an open-market purchase or sale). The share withholding for taxes is a routine administrative step and is not the same as an open-market sale that signals a personal liquidity decision.
- For retail investors, this is informational about executive compensation and potential future dilution as remaining RSUs vest and convert into shares.
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Blum Susan
Chief Financial Officer
Transactions
- Award
Common Stock
[F1]2026-01-23+72,820→ 142,506 total - Tax Payment
Common Stock
2026-01-23$7.27/sh−9,767$71,006→ 132,739 total
Footnotes (1)
- [F1]These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
Signature
/s/ Beth Zelnick Kaufman, attorney-in-fact|2026-01-27